Comparative Diagnostic Performance of Amyloid‐β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head‐to‐Head Meta‐Analysis

Comparative Diagnostic Performance of Amyloid‐β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head‐to‐Head Meta‐Analysis

ABSTRACT Objective This meta‐analysis aimed to evaluate the comparative diagnostic performance of amyloid‐β positron emission tomography (Aβ PET) and magnetic resonance imaging (MRI) in diagnosing Alzheimer's disease (AD). Methods An extensive search was conducted in the PubMed and Embase datab...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fang Li, Jiang Cheng, Kaihui Jin, Li Zhao, Junyong Li, Jia Wu, Xiaolu Ren
Format:	Article
Language:	English
Published:	Wiley 2024-10-01
Series:	Brain and Behavior
Subjects:	Alzheimer's disease amyloid‐β magnetic resonance imaging positron emission tomography
Online Access:	https://doi.org/10.1002/brb3.70111
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of standardized uptake value ratio calculations in amyloid positron emission tomography brain imaging
by: Karin Knesaurek, et al.
Published: (2018-01-01)

Phototherapy via Modulation of β‐Amyloid in Combating Alzheimer's Disease
by: Yunhua Zhang, et al.
Published: (2025-05-01)

Accuracy of quantitative positron emission tomography assessment for differentiating cerebral age-related from pathological amyloid deposition: A preliminary report from a case-series study
by: Fulvio Lauretani, et al.
Published: (2018-04-01)

β-Amyloids and Immune Responses Associated with Alzheimer’s Disease
by: Elizaveta Kolobova, et al.
Published: (2024-09-01)

Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy
by: Shiwani Randhawa, et al.
Published: (2025-04-01)

Amyloid-β Inhibiting Peptides: An Innovative Strategy for Alzheimer’s Disease Treatment
by: Sajjad Molavipordanjani, et al.
Published: (2023-11-01)

Mannose Promotes β‐Amyloid Pathology by Regulating BACE1 Glycosylation in Alzheimer's Disease
by: Chensi Liang, et al.
Published: (2025-03-01)

Unraveling the complex role of microglia in Alzheimer’s disease: amyloid β metabolism and plaque formation
by: Sho Takatori, et al.
Published: (2025-05-01)

Development of a Japanese polygenic risk score model for amyloid-β PET imaging in Alzheimer’s disease
by: Misato Kaishima, et al.
Published: (2025-05-01)

New insights into the 17β-hydroxysteroid dehydrogenase type 10 and amyloid-β 42 derived cytotoxicity relevant to Alzheimer’s disease
by: Aneta Houfková, et al.
Published: (2025-07-01)

Compensatory enhancement of orexinergic system functionality induced by amyloid-β protein: a neuroprotective response in Alzheimer’s disease
by: Chenyu Zhuang, et al.
Published: (2025-03-01)

Distinct Chemical Determinants are Essential for Achieving Ligands for Superior Optical Detection of Specific Amyloid‐β Deposits in Alzheimer's Disease
by: Dr. Xiongyu Wu, et al.
Published: (2024-12-01)

Degradation of amyloid β-peptides catalyzed by nattokinase in vivo and in vitro
by: Aixin Ni, et al.
Published: (2023-09-01)

CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01)

N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer’s Disease Research
by: Citlali Gutiérrez, et al.
Published: (2025-06-01)

Anti-amyloid β hydrophobic peptides in Alzheimer’s disease: biomarkers and therapeutic potential
by: Carlos Gutierrez-Merino
Published: (2025-02-01)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
by: Sebastian Palmqvist, et al.
Published: (2019-11-01)

Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model
by: Kunie Ando, et al.
Published: (2025-01-01)

Head to head comparison of two PET/CT imaging agents, [18F]D3FSP ([18F]P16-129) and [18F]AV45, in patients with alzheimer’s disease
by: David Alexoff, et al.
Published: (2025-06-01)

Positron Emission Tomography in Cerebral Amyloid Angiopathy: A Scoping Review
by: Marialuisa Zedde, et al.
Published: (2025-04-01)

Amyloid β perturbs elevated heme flux induced with neuronal development
by: Chantal Vidal, et al.
Published: (2019-01-01)

Computational discovery of plant-derived flavonoids as potential amyloid-β fibril disaggregating agents for alzheimer’s disease
by: Uthirapathi Logeswari Rakesh, et al.
Published: (2025-06-01)

Neuroprotective potential of quercetin in Alzheimer’s disease: targeting oxidative stress, mitochondrial dysfunction, and amyloid-β aggregation
by: Mohd Adnan, et al.
Published: (2025-06-01)

The Role of CSF Biomarkers in Discriminating Between Cerebral Amyloid Angiopathy and Alzheimer’s Disease Patients: Systematic Review of Clinical Studies
by: Zahra Razmkhah, et al.
Published: (2024-10-01)

Improving 18F-Fluoro-D-Glucose-Positron Emission Tomography/Computed Tomography Imaging in Alzheimer′s Disease Studies
by: Karin Knešaurek
Published: (2015-07-01)

Moderate‐ to high‐intensity exercise does not modify cortical β‐amyloid in Alzheimer's disease
by: Kristian S. Frederiksen, et al.
Published: (2019-01-01)

Traumatic Brain Injury and Genetic Risk for Alzheimer’s Disease Impact Cerebrospinal Fluid β-Amyloid Levels in Vietnam War Veterans
by: Jena N. Moody, et al.
Published: (2024-11-01)

Nasal Aβ42 mirrors brain amyloid dynamics and cognitive decline across the Alzheimer’s disease continuum
by: Da Hae Jung, et al.
Published: (2025-08-01)

Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged β-amyloid nanoscavenger for Alzheimer's disease therapy
by: Yanyan Xu, et al.
Published: (2025-06-01)

Distribution of β-amyloid and pTau in brain cortex depending on age and mental state
by: Alexandra V. Sentyabreva, et al.
Published: (2024-12-01)

Reevaluating the role of amyloid β-peptides in Alzheimer’s disease: from pathogenic agents to protective chelation mechanisms
by: Franco Cavaleri
Published: (2025-03-01)

Efficient strategy for alleviating neuronal apoptosis and oxidative stress damage of Alzheimer's disease through dual targeting BCL-2 gene promoter i-motif and β-amyloid
by: Dongsheng Ji, et al.
Published: (2025-05-01)

The First Application of Positron Emission Tomography/ Magnetic Resonance Imaging in Russia
by: A. S. Chaban, et al.
Published: (2019-06-01)

Amyloid blood biomarker detects Alzheimer's disease
by: Andreas Nabers, et al.
Published: (2018-04-01)

Amyloid-β-induced alteration of fast and localized calcium elevations in cultured astrocytes
by: Kaito Nakata, et al.
Published: (2025-05-01)

Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice
by: Kiwami Kidana, et al.
Published: (2018-01-01)

Role of fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of head and neck carcinoma
by: Moheieldin Abouzied, et al.
Published: (2017-10-01)

Disruption of hnRNP A2-mediated RNA dynamics by amyloid-β drives MBP increase in Alzheimer’s disease
by: Adhara Gaminde-Blasco, et al.
Published: (2025-08-01)

Amyloid β (Aβ) inhibits retinal angiogenesis in Alzheimer's disease via LncRNA-XIST/miRNA-126-5p/VEGF axis
by: Bin Wang, et al.
Published: (2025-07-01)

PU.1 dictates β-amyloid-induced TREM2 expression upregulation in microglia in a transgenic model of Alzheimer’s disease
by: Zhen Wei, et al.
Published: (2025-05-01)